<DOC>
	<DOCNO>NCT00799656</DOCNO>
	<brief_summary>The primary objective study assess efficacy ataciguat versus placebo reduce pain intensity patient neuropathic pain . The secondary objective ass safety tolerability ataciguat versus placebo .</brief_summary>
	<brief_title>Efficacy Safety Study Ataciguat Versus Placebo Patients With Neuropathic Pain</brief_title>
	<detailed_description>This study consist two consecutive 28 day treatment period separate 2 week medication free period safety follow-up period 2 week second treatment period .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>Patients chronic neuropathic pain due diabetic polyneuropathy nerve lesion follow surgery . The pain must present 3 month . Presence history cancer within past five year Patients history HIV infection Patients active hepatitis B C Patients pain neuropathic pain great equal severity Patients diabetes mellitus less 6 month The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Diabetic neuropathy</keyword>
	<keyword>painful pain</keyword>
	<keyword>postoperative</keyword>
</DOC>